This inventor holds 3 USPTO granted patents. Top assignee: University of Virginia Patent Foundation. Active years: 1998-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sol, KR (1998)
- Sung Bu ku Sol, KR (2000)
- Anam-Dong, KR (2003)
Company Filing History:
Years Active: 1998-2003
Title: Innovations by Jun Cheon
Introduction
Jun Cheon is an accomplished inventor based in Anam-Dong, South Korea. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of various cancers. With a total of 3 patents, his work focuses on utilizing advanced genetic techniques to improve cancer treatment outcomes.
Latest Patents
One of Jun Cheon's latest patents involves the utilization of an osteocalcin promoter to deliver therapeutic genes to tumors. This innovative therapeutic agent, based on a recombinant adenovirus, employs the osteocalcin promoter for the expression of thymidine kinase. It can be administered intravascularly to treat metastatic cancers, including osteosarcoma, breast cancer, prostate cancer, ocular melanoma, and brain cancer. The systemic administration of this agent is preferred over previous methods of local direct administration. Additionally, this therapeutic agent can also be effectively used in treating benign conditions such as benign prostatic hypertrophy and arteriosclerosis.
Another significant patent focuses on the in vivo suppression of osteosarcoma pulmonary metastasis. Similar to his previous work, this therapeutic agent utilizes a recombinant adenovirus with an osteocalcin promoter for thymidine kinase expression. The systemic administration approach enhances the effectiveness of the treatment for metastatic cancers and benign conditions.
Career Highlights
Jun Cheon is associated with the University of Virginia Patent Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
He has collaborated with notable colleagues, including Chinghai Kao and Robert A. Sikes, contributing to the development of groundbreaking therapeutic solutions.
Conclusion
Jun Cheon's innovative work in the field of therapeutic agents showcases his commitment to improving cancer treatment through advanced genetic techniques. His contributions are paving the way for more effective therapies and better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile